Joint Placement Agent on Ovid Therapeutics' Private Placement Financing

Oppenheimer & Co. Inc. October 08, 2025
Oppenheimer & Co. Inc. acted as Joint Placement Agent on Ovid Therapeutics’ Private Placement Financing of up to $175.0 Million

Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing small molecule medicines for brain conditions with significant unmet need, today announced that it has entered into a securities purchase agreement for a private investment in public equity (“PIPE”) financing that is expected to result in gross proceeds of up to $175 million to the Company, including initial gross proceeds of approximately $81 million, in each case before placement agent fees and offering expenses. The PIPE financing is expected to close on or about October 6, 2025, subject to satisfaction of customary closing conditions.

The PIPE financing included participation from new investors Janus Henderson Investors, RA Capital Management, Eventide Asset Management, Coastlands Capital, Blue Owl Healthcare Opportunities, Balyasny Asset Management, Saturn V Capital and Ally Bridge Group, alongside existing investors including ADAR1 Capital Management and Affinity Healthcare Fund, LP, as well as new and existing large investment management firms.

The Company intends to use the net proceeds from the initial closing of the PIPE financing, together with the Company’s existing cash, cash equivalents and marketable securities, to provide financing for research and development, general corporate expenses, and working capital needs. The Company expects that its cash will fund its operating plan into 2028.

Healthcare Life Science Investment Banking 

Michael A. Margolis, R.Ph.
Name:

Michael A. Margolis, R.Ph.

Title:

Senior Managing Director, Head of Healthcare Investment Banking

Stefan Loren, Ph.D.
Name:

Stefan Loren, Ph.D.

Title:

Managing Director, Healthcare Investment Banking

Healthcare Equity Capital Markets

Andy Linderman
Name:

Andy Linderman

Title:

Managing Director, Healthcare Capital Markets Investment Banking

Name:

James Yoo

Title:

Managing Director, Healthcare Capital Markets Investment Banking

DISCLOSURES

This notice is provided for informational purposes only and is not intended as a recommendation or an offer or solicitation for the purchase or sale of any security or financial instrument. Nothing contained herein shall constitute an offer or solicitation to buy or sell any securities discussed herein in any jurisdiction where such offer or solicitation would be prohibited.

This notice may contain statistical data cited from third-party sources believed to be reliable, but Oppenheimer & Co. Inc. does not represent that any such third-party statistical information is accurate or complete, and it should not be relied upon as such. All market prices, data and other information are not warranted as to completeness or accuracy and are subject to change without notice.

Oppenheimer & Co. Inc. Transacts Business on all Principal US Exchanges and is a Member of SIPC. 8463625.1